Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

 

Angiogenesis

Deep Insight

Angiogenic factors and cancer therapy
DNA methylation in cancer
FOXP3 expression in tumor cells and its role in cancer progression

Genes

AAMP (angio-associated, migratory cell protein)
ACVRL1 (activin A receptor type II-like 1)
ADAMTS9 (ADAM metallopeptidase with thrombospondin type 1 motif, 9)
AKAP12 A kinase (PRKA) anchor protein 12
ANG (angiogenin, ribonuclease, RNase A family, 5)
APLNR (apelin receptor)
AQP1 (aquaporin 1 (Colton blood group))
ATF4 (activating transcription factor 4 (tax-responsive enhancer element B67))
ATP5B (ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide)
AXL (AXL receptor tyrosine kinase)
BAG3 (Bcl-2 associated athanogene 3)
BAK1 (BCL2-antagonist/killer 1)
BEX2 (brain expressed X-linked 2)
CCR1 (chemokine (C-C motif) receptor 1)
CD151 (CD151 molecule (Raph blood group))
CD248 (CD248 molecule, endosialin)
CD47 (Cluster of Differentiation 47)
CD59 (CD59 molecule, complement regulatory protein)
ADGRE5 (CD97 molecule)
CLIC4 (chloride intracellular channel 4)
CPM (carboxypeptidase M)
CX3CL1 (chemokine (C-X3-C motif) ligand 1)
CXCL10 (chemokine (C-X-C motif) ligand 10)
CXCL12 (chemokine (C-X-C motif) ligand 12)
CXCL17 (chemokine (C-X-C motif) ligand 17)
CXCL5 (chemokine (C-X-C motif) ligand 5)
CXCR1 (chemokine (C-X-C motif) receptor 1)
CYP4B1 (cytochrome P450, family 4, subfamily B, polypeptide 1)
CYR61 (cysteine-rich, angiogenic inducer, 61)
DIRAS3 (DIRAS family, GTP-binding RAS-like 3)
DLX4 (distal-less homeobox 4)
DPP4 (dipeptidyl-peptidase 4)
ECM1 (extracellular matrix protein 1)
EDIL3 (EGF-Like Repeats And Discoidin I-Like Domains 3)
EEF2K (eukaryotic elongation factor 2 kinase)
ENG (endoglin)
ENPP2 (ectonucleotide pyrophosphatase/phosphodiesterase 2)
ENPP7 (ectonucleotide pyrophosphatase/phosphodiesterase 7)
EPHA2 (EPH receptor A2)
EPS8 (epidermal growth factor receptor pathway substrate 8)
ERBB3 (v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian))
FAP (fibroblast activation protein alpha)
FBLN5 (fibulin 5)
FGF2 (fibroblast growth factor 2 (basic))
FGF8 (fibroblast growth factor 8 (androgen-induced))
VEGFD (c-fos induced growth factor (vascular endothelial growth factor D))
FPR1 (formyl peptide receptor 1)
GBP1 (guanylate binding protein 1, interferon-inducible, 67kDa)
HIPK2 (homeodomain interacting protein kinase 2)
HLTF (helicase-like transcription factor)
ID1 (inhibitor of DNA binding 1, dominant negative helix-loop-helix protein)
IGFBP6 (insulin-like growth factor binding protein 6)
IL17A (interleukin 17A)
ILK (integrin-linked kinase)
ING4 (inhibitor of growth family, member 4)
KDR (kinase insert domain receptor)/Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
KLF5 : Kruppel-like factor 5 (intestinal)
LGALS3 (lectin, galactoside-binding, soluble, 3)
LPAR2 (lysophosphatidic acid receptor 2)
MIF (macrophage migration inhibitory factor (glycosylation-inhibiting factor))
MIR100 (microRNA 100)
MIR107 (MicroRNA 107)
MMP14 (matrix metallopeptidase 14 (membrane-inserted))
MMP19 (matrix metallopeptidase 19)
MMP2 (matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase).
MMP9 (matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase))
MRC1 (mannose receptor, C type 1)
MST1 (macrophage stimulating 1 (hepatocyte growth factor-like))
NAMPT (nicotinamide phosphoribosyltransferase)
NCOA1 (Nuclear receptor coactivator 1)
NDRG1 (N-myc downstream regulated 1)
NDUFA13 (NADH:ubiquinone oxidoreductase subunit A13)
NKX2-3 (NK2 homeobox 3)
NOTCH1 (Notch homolog 1, translocation-associated (Drosophila))
NOTCH2 (Notch homolog 2 (Drosophila))
NOTCH3 (Notch homolog 3 (Drosophila))
NPY1R (neuropeptide Y receptor Y1)
NR3C1 (nuclear receptor subfamily 3, group C, member 1/glucocorticoid receptor)
NT5E (5'-nucleotidase, ecto (CD73))
PF4 (platelet factor 4)
PF4V1 (Platelet Factor 4 Variant 1)
PGR (progesterone receptor)
PIM1 (pim-1 oncogene)
PLA2G4A (phospholipase A2, group IVA (cytosolic, calcium-dependent))
PLCG1 (Phospholipase C, Gamma 1)
PML (promyelocytic leukemia)
PTK7 (PTK7 protein tyrosine kinase 7)
PTN (pleiotrophin)
PTPN14 (protein tyrosine phosphatase, non-receptor type 14)
REST (RE1-silencing transcription factor)
RET (REarranged during Transfection)
RLN2 (relaxin 2)
S100A4 (S100 Calcium Binding Protein A4)
SGK1 (serum/glucocorticoid regulated kinase 1)
TEK (TEK tyrosine kinase, endothelial)
TGFBR3 (transforming growth factor, beta receptor III)
THBS1 (thrombospondin-1)
THRB (Thyroid Hormone Receptor, Beta)
TIE1 (tyrosine kinase with immunoglobulin-like and EGF-like domains 1)
TIMP2 (TIMP metallopeptidase inhibitor 2)
TMSB10 (thymosin beta 10)
TNC (tenascin C (hexabrachion))
TNFSF15 (tumor necrosis factor (ligand) superfamily, member 15)
TSPAN8 (tetraspanin 8)
TYMP (thymidine phosphorylase)
UTS2 (urotensin 2)
VAV3 (vav 3 guanine nucleotide exchange factor)
VHL (von Hippel-Lindau tumor suppressor)
WFDC1 (WAP four-disulfide core domain 1)

Iconography


Figure from ACVRL1


Figure from ADAMTS9


Figure from APLNR


Figure from ATP5B


Figure from AXL


Figure from BAK1


Figure from CCR1


Figure from CD151


Figure from CD248


Figure from CD97


Figure from CLIC4


Figure from CXCL12


Figure from CXCR1


Figure from DIRAS3


Figure from DPP4


Figure from ECM1


Figure from ENPP2


Figure from ENPP7


Figure from EPHA2


Figure from EPHA2


Figure from ERBB3


Figure from FBLN5


Figure from FGF2


Figure from FPR1


Figure from GBP1


Figure from IGFBP6


Figure from ILK


Figure from ILK


Figure from KDR


Figure from KLF5


Figure from LPAR2


Figure from MIR100


Figure from MIR100


Figure from MMP14


Figure from MMP2


Figure from MRC1


Figure from MST1


Figure from NDRG1


Figure from NDUFA13


Figure from NKX2-3


Figure from NR3C1


Figure from PF4


Figure from PLCG1


Figure from PTK7


Figure from PTPN14


Figure from SGK1


Figure from TEK


Figure from TEK


Figure from TGFBR3


Figure from TIE1


Figure from UTS2


Figure from VHL


Figure from ANG


Figure from MMP9


Figure from TIMP2


Figure from TNC


Figure from VHL


Figure from WFDC1


Figure from CYP4B1


Figure from ECM1


Figure from MMP19


Figure from NOTCH2


Figure from FBLN5


Figure from AKAP12


Figure from CD59


Figure from CXCL5


Figure from FGF8


Figure from VEGFD


Figure from PTPN14


Figure from CD47


Figure from PTN


Figure from CPM


Figure from DLX4


Figure from NDUFA13


Figure from TNFSF15


Figure from CX3CL1


Figure from CYR61


Figure from EEF2K


Figure from NPY1R


Figure from RLN2


Figure from BAG3


Figure from NDRG1


Figure from DPP4


Figure from KDR


Figure from RET


Figure from CXCL10


Figure from FPR1


Figure from PGR


Figure from S100A4


Figure from THBS1


Figure from NCOA1


Figure from FAP


Figure from CXCL12


Figure from PML

Contributor(s)

WrittenOct 2009Jean-Loup Huret
UpdatedMar 2021Jean-Loup Huret and Philippe Dessen

Citation

This paper should be referenced as such :
, Huret JL, Dessen P.. Angiogenesis. Atlas Genet Cytogenet Oncol Haematol. Mar 2021 .
URL : http://AtlasGeneticsOncology.org/Categories/Angiogenesis.html


© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Thu Mar 25 21:08:09 CET 2021

Home   Genes   Leukemias   Solid Tumors   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA